EU Support Gilenya with stronger warning on heart risk, believes the benefit out weighs the risk
docs should not diagnose to those with cardiovascular or cerebra-vascular disease and those on heart lowering medication
if treatment is necessary with those patients heart monitoring should go on for at least overnight following the first dose.
http://www.reuters.com/article/2012/...83J0EG20120420
docs should not diagnose to those with cardiovascular or cerebra-vascular disease and those on heart lowering medication
if treatment is necessary with those patients heart monitoring should go on for at least overnight following the first dose.
http://www.reuters.com/article/2012/...83J0EG20120420
Comment